Junqing Yue

2.6k total citations · 1 hit paper
9 papers, 1.7k citations indexed

About

Junqing Yue is a scholar working on Infectious Diseases, Neurology and Physiology. According to data from OpenAlex, Junqing Yue has authored 9 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Neurology and 4 papers in Physiology. Recurrent topics in Junqing Yue's work include COVID-19 Clinical Research Studies (4 papers), Asthma and respiratory diseases (4 papers) and Long-Term Effects of COVID-19 (4 papers). Junqing Yue is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Asthma and respiratory diseases (4 papers) and Long-Term Effects of COVID-19 (4 papers). Junqing Yue collaborates with scholars based in China, Germany and United States. Junqing Yue's co-authors include Min Xie, Xiansheng Liu, Shuyun Xu, Xiaochen Li, Ke Wang, Min Zhou, Muqing Yu, Bo Wu, Jing Shi and Ying Zhou and has published in prestigious journals such as ACS Nano, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Junqing Yue

9 papers receiving 1.7k citations

Hit Papers

Risk factors for severity and mortality in adult COVID-19... 2020 2026 2022 2024 2020 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junqing Yue China 7 1.3k 689 383 226 196 9 1.7k
Muqing Yu China 7 1.2k 1.0× 673 1.0× 386 1.0× 231 1.0× 191 1.0× 11 1.7k
Luke O’Donnell United Kingdom 3 1.3k 1.0× 674 1.0× 497 1.3× 182 0.8× 209 1.1× 7 1.8k
Jiahao Peng United States 7 1.1k 0.8× 535 0.8× 385 1.0× 128 0.6× 209 1.1× 18 1.7k
Buyun Xu China 7 1.1k 0.8× 531 0.8× 357 0.9× 115 0.5× 209 1.1× 19 1.7k
Yangbo Xing China 9 1.1k 0.8× 531 0.8× 361 0.9× 117 0.5× 210 1.1× 23 1.7k
Pingzheng Mo China 13 1.8k 1.5× 981 1.4× 376 1.0× 117 0.5× 191 1.0× 25 2.3k
Mingqi Luo China 9 1.4k 1.1× 791 1.1× 462 1.2× 114 0.5× 133 0.7× 26 1.8k
Shihui Song China 7 1.5k 1.2× 868 1.3× 314 0.8× 98 0.4× 153 0.8× 16 1.8k

Countries citing papers authored by Junqing Yue

Since Specialization
Citations

This map shows the geographic impact of Junqing Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqing Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqing Yue more than expected).

Fields of papers citing papers by Junqing Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqing Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqing Yue. The network helps show where Junqing Yue may publish in the future.

Co-authorship network of co-authors of Junqing Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Junqing Yue. A scholar is included among the top collaborators of Junqing Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqing Yue. Junqing Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhang, Weiyun, Qin Lu, Junqing Yue, et al.. (2025). Targeted Knockdown of Epithelial Estrogen Receptor α to Mitigate Ferroptosis and Epithelial–Mesenchymal Transition in Eosinophilic Asthma. ACS Nano. 19(22). 21105–21117. 2 indexed citations
2.
Guan, Wei‐jie, Yilin Zhang, Lei Chen, et al.. (2024). SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl− concentration. Signal Transduction and Targeted Therapy. 9(1). 74–74. 18 indexed citations
3.
Lu, Qin, et al.. (2023). Estrogen Receptor-α Exacerbates EGF-Inducing Airway Remodeling and Mucus Production in Bronchial Epithelium of Asthmatics. Allergy Asthma and Immunology Research. 15(5). 614–614. 6 indexed citations
4.
Chen, Li, Junqing Yue, Qin Lu, et al.. (2022). SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma. Frontiers in Immunology. 13. 947724–947724. 2 indexed citations
5.
Yue, Junqing, Qin Lu, Cong Zhang, et al.. (2021). Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors. Scientific Reports. 11(1). 13854–13854. 41 indexed citations
6.
7.
Li, Xiaochen, Shuyun Xu, Muqing Yu, et al.. (2020). Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology. 146(1). 110–118. 1537 indexed citations breakdown →
8.
Lu, Qin, Zhen Li, Yu Fan, et al.. (2020). Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function. Respiratory Medicine. 175. 106208–106208. 6 indexed citations
9.
Lu, Qin, Xiaochen Li, Jing Shi, et al.. (2020). Gendered effects on inflammation reaction and outcome of COVID‐19 patients in Wuhan. Journal of Medical Virology. 92(11). 2684–2692. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026